Pavel A. Andoskin
Saint Petersburg, SPE 197022, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Development of Graphene-Based Materials with the Targeted Action for Cancer Theranostics.
Journal: Biochemistry. Biokhimiia
Published: September 08, 2024
Application of carbon nanostructures in biomedicine: realities, difficulties, prospects.
Journal: Nanotoxicology
Published: March 15, 2024
Increased α-Synuclein Level in CD45+ Blood Cells in Asymptomatic Carriers of GBA Mutations.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: April 08, 2021
Short-term renal and metabolic effects of low dose vildagliptin treatment added-on insulin therapy in non-proteinuric patients with type 2 diabetes: open-label randomized prospective study.
Journal: Archives of endocrinology and metabolism
Published: April 17, 2019
SNCA variants and alpha-synuclein level in CD45+ blood cells in Parkinson's disease.
Journal: Journal of the neurological sciences
Published: September 27, 2017
Oligomeric α-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson's disease.
Oligomeric α-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson's disease.
Journal: Neuroscience letters
Published: July 26, 2016
SNCA rs356219 AND rs356165 VARIANTS ARE ASSOCIATED WITH PARKINSON'S DISEASE AND INCREASED ALPHA-SYNUCLEIN GENE EXPRESSION IN THE CD45(+)-BLOOD CELLS
Journal: Tsitologiia
Published: May 28, 2016
SNCA, LRRK2, MAPT polymorphisms and Parkinson's disease in Russia.
Journal: Parkinsonism & related disorders
Published: March 04, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026